News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avita Medical Granted European Patent Covering Platform Technology


4/5/2012 10:20:23 AM

NORTHRIDGE, Calif. & CAMBRIDGE, England--(BUSINESS WIRE)--Avita Medical Ltd. (ASX:AVH) (OTCQX:AVMXY), the regenerative medicine company, has been granted European patent EP1357922B1 “Cell Suspension Preparation Technique and Use” by the European Patent Office. The patent covers broad claims related to the preparation of a cell suspension comprised of the patient’s own epithelial cells (autologous suspension), the therapeutic use of the cell suspension and, importantly, a ‘composition of matter’ claim wherein the actual suspension of autologous cells is covered.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES